Infant Bacterial Therapeutics AB logo

IBT B - Infant Bacterial Therapeutics AB News Story

SEK101 -0.2  -0.2%

Last Trade - 12:33pm

Sector
Healthcare
Size
Small Cap
Market Cap £97.4m
Enterprise Value £61.1m
Revenue £n/a
Position in Universe 915th / 1829

BRIEF-Infant Bacterial Therapeutics Gets New Patent Protection In Japan

Wed 10th February, 2021 10:32am
Feb 10 (Reuters) - Infant Bacterial Therapeutics AB
 IBTb.ST :
    * SAID ON TUESDAY THAT JAPAN PATENT OFFICE HAS ISSUED A
DECISION
TO GRANT A PATENT 
    * PATENT FURTHER INCREASES THE EXISTING PROTECTION OF DRUG
CANDIDATE IBP-9414 FOR WHICH BOTH ORPHAN DRUG EXCLUSIVITY AND
BIOLOGICAL DATA PROTECTION HAVE BEEN GRANTED IN THE USA AND EU
    * JAPANESE PATENT EXPIRES IN 2036

    
    
 Source text for Eikon:  urn:newsml:reuters.com:*:nGNE9KmJll
    
 Further company coverage:  IBTb.ST  
   


 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.